4
Changes in Ownership
Obsidian Therapeutics, Inc. Filed Acc 0001193125-26-335082
Options or other derivatives
- Chief Executive Officer acquired 37,653 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Jagasia Madan · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-03 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +37,653 | 37,653 | D |
Loading xslF345X06/ownership.xml…